{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:50:08Z","timestamp":1790617808016,"version":"4.1.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Aims\/background<\/jats:title>\n                    <jats:p>As cannabis use continues to increase in the United States, racialized stereotypes and structural barriers to care might lead to inequitable treatment uptake across racialized groups. A greater understanding of racial disparities in cannabis treatment uptake and perceived treatment need among people with cannabis use disorder (CUD) in community-based samples is needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Nationally representative data from the 2002\u20132019 National Survey on Drug Use and Health (N=1,005,421) included community-based people ages 12+ First, we assessed trends in CUD (i.e., meeting 2+ DSM-5 proxy CUD criteria) by racialized group. Among people with CUD (n=48,768), weighted logistic models regressed any CUD treatment, specialty CUD treatment, and perceived need for CUD treatment on racialized group and year, adjusting for age, gender, education, insurance, and criminal legal system exposure. We use interaction terms to examine group-specific trend differences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 2.64% of the US population ages 12+ had CUD, including 2.47% of white, 1.23% of AAPI (Asian American and Pacific Islander), 4.83% of AIAN (American Indian and Alaska Native), 3.70% of Black, and 2.71% of Hispanic people. CUD increased slightly across all groups (overall annual OR: 1.01, 95% CI =1.01,1.02), with AAPI, Hispanic and people with more than one race seeing steeper increases (ORs: 1.02-1.04). Treatment use and perceived need decreased consistently and there were no group differences in these trends across racialized groups with CUD (ORs: 0.93-0.97). Black people with CUD had 21% lower odds of any treatment than white people (aOR: 0.79, 95% CI=0.65, 0.95). All racialized groups (except AAPI people) had higher odds of perceived need than white people (aORs: 1.59\u20131.73).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Although all racialized groups had increasing CUD and decreasing CUD treatment use during the study period, the observed racialized disparities also persisted. For example, despite a higher prevalence of CUD among Black people compared to white people, Black people with CUD were less likely than their white counterparts to receive treatment and more likely to report perceived need. These disparities in CUD, treatment use, and perceived need underscore the need for CUD-related services overall and tailored services for racialized minorities, and especially Black people.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2025.1689719","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:28:51Z","timestamp":1762324131000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Trends in cannabis use disorder and treatment by race and ethnicity, 2002\u20132019"],"prefix":"10.3389","volume":"16","author":[{"given":"Mireia","family":"Triguero Roura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aabha","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan L.","family":"Eschliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia M.","family":"Mauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"B1","unstructured":"2025"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108873","article-title":"Joint perceptions of the risk and availability of Cannabis in the United States 2002-2018","volume":"226","author":"Levy","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"B3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.drugalcdep.2016.04.029","article-title":"Those edibles hit hard\u201d: Exploration of Twitter data on cannabis edibles in the U.S","volume":"164","author":"Lamy","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.27002","article-title":"Racial and ethnic differences in cannabis use following legalization in US states with medical cannabis laws","volume":"4","author":"Martins","year":"2021","journal-title":"JAMA Network Open"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.04.016","article-title":"Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003\u201311","volume":"140","author":"Schuermeyer","year":"2014","journal-title":"Drug Alcohol Depend"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2025.1156","article-title":"Trends in past-month cannabis use among older adults","volume":"185","author":"Han","year":"2025","journal-title":"JAMA Internal Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.copsyc.2021.03.005","article-title":"Trends over time in adult cannabis use: A review of recent findings","volume":"38","author":"Hasin","year":"2021","journal-title":"Curr Opin Psychol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2174\/13816128113199990620","article-title":"Acute and long-term effects of cannabis use: A review","volume":"20","author":"Karila","year":"2014","journal-title":"Curr Pharm Design"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e536","article-title":"Acute cannabis consumption and motor vehicle collision risk: Systematic review of observational studies and meta-analysis","volume":"344","author":"Asbridge","year":"2012","journal-title":"BMJ (Clinical Res Ed.)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2015.12.002","article-title":"Acute and chronic effects of cannabinoids on human cognition\u2014A systematic review","volume":"79","author":"Broyd","year":"2016","journal-title":"Biol Psychiatry"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.15070907","article-title":"Prevalence and correlates of DSM-5 cannabis use disorder 2012-2013: findings from the national epidemiologic survey on alcohol and related conditions\u2013III","volume":"173","author":"Hasin","year":"2016","journal-title":"Am J Psychiatry"},{"key":"B12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/jamapsychiatry.2015.3278","article-title":"Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: A review","volume":"73","author":"Volkow","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.22010034","article-title":"Trends in cannabis use disorder diagnoses in the U.S. Veterans health administration 2005\u20132019","volume":"179","author":"Hasin","year":"2022","journal-title":"Am J Psychiatry"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002920","article-title":"Increasing risk of cannabis use disorder among U.S. veterans with chronic pain: 2005-2019","volume":"164","author":"Mannes","year":"2023","journal-title":"Pain"},{"key":"B15","doi-asserted-by":"publisher","first-page":"107468","DOI":"10.1016\/j.drugalcdep.2019.05.008","article-title":"Cannabis use disorders among adults in the United States during a time of increasing use of cannabis","volume":"204","author":"Compton","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109154","article-title":"Cannabis use disorder treatment use and perceived treatment need in the United States: Time trends and age differences between 2002-2019","volume":"229","author":"Askari","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2024.111113","article-title":"Associations between cannabis policies and state-level specialty cannabis use disorder treatment in the United States 2004\u20132019","volume":"257","author":"Mauro","year":"2024","journal-title":"Drug Alcohol Depend"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2021.107049","article-title":"Young adult cannabis use disorder treatment admissions declined as past month cannabis use increased in the U.S.: An analysis of states by year 2008\u20132017","volume":"123","author":"Mennis","year":"2021","journal-title":"Addictive Behav"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005336.pub4","article-title":"Psychosocial interventions for cannabis use disorder","volume":"2016","author":"Gates","year":"2016","journal-title":"Cochrane Database Systematic Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s11469-023-01012-2","article-title":"Alcohol or drug self-help use among adults in the United States: age, period, and cohort effects between 2002 and 2018","volume":"22","author":"Mauro","year":"2024","journal-title":"Int J Ment Health Addict"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13137","article-title":"Treatment utilization among adolescent substance users: findings from the 2002 to 2013 national survey on drug use and health","volume":"40","author":"Haughwout","year":"2016","journal-title":"Alcoholism: Clin Exp Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.drugalcdep.2012.06.012","article-title":"Perceived unmet need for alcohol and drug use treatments and future use of services: Results from a longitudinal study","volume":"127","author":"Mojtabai","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189900","article-title":"Racism and health service utilisation: A systematic review and meta-analysis","volume":"12","author":"Ben","year":"2017","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1176\/ps.62.11.pss6211_1273","article-title":"Racial-ethnic disparities in substance abuse treatment: The role of criminal history and socioeconomic status","volume":"62","author":"Cook","year":"2011","journal-title":"Psychiatr Serv (Washington D.C.)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/15332640.2018.1548323","article-title":"Anti-racism and substance use treatment: Addiction does not discriminate, but do we","volume":"19","author":"Matsuzaka","year":"2020","journal-title":"J Ethnicity Subst Abuse"},{"key":"B26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev-clinpsy-081423-023228","article-title":"Mental illness and substance use disorder stigma: mapping pathways between structures and individuals to accelerate research and intervention","volume":"21","author":"Earnshaw","year":"2025","journal-title":"Annu Rev Clin Psychol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2301304120","article-title":"Differential spatial-social accessibility to mental health care and suicide","volume":"120","author":"Tadmon","year":"2023","journal-title":"Proc Natl Acad Sci"},{"key":"B28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1108\/S1057-6290(2012)0000014008","article-title":"Two tiers of biomedicalization: METHADONE buprenorphine and the racial politics of addiction treatment","volume-title":"Critical perspectives on addiction","author":"Hansen","year":"2012"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2017.1385633","article-title":"At the expense of a life: race, class, and the meaning of buprenorphine in pharmaceuticalized \u201cCare","volume":"53","author":"Hatcher","year":"2018","journal-title":"Subst Use Misuse"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1037\/sah0000426","article-title":"Intersectional stigma as a fundamental cause of health disparities: A case study of how drug use stigma intersecting with racism and xenophobia creates health inequities for Black and Hispanic persons who use drugs over time","volume":"8","author":"Walters","year":"2023","journal-title":"Stigma Health"},{"key":"B31","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1037\/lhb0000510","article-title":"A call to dismantle systemic racism in criminal legal systems","volume":"46","author":"Najdowski","year":"2022","journal-title":"Law Hum Behav"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S183256","article-title":"Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders","volume":"9","author":"Hammarlund","year":"2018","journal-title":"Subst Abuse Rehabil"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/bs6040021","article-title":"Black-white disparities in criminal justice referrals to drug treatment: addressing treatment need or expanding the diagnostic net","volume":"6","author":"McElrath","year":"2016","journal-title":"Behav Sci (Basel Switzerland)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.06.002","article-title":"Trends in cannabis use disorders among racial\/ethnic population groups in the United States","volume":"165","author":"Wu","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20231060","article-title":"12-month prevalence estimates of substance use disorders using DSM-5 versus DSM-IV criteria among U.S. Nonelderly adults with substance use","volume":"181","author":"Compton","year":"2024","journal-title":"Am J Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2022.09.016","article-title":"Construct validity of DSM-5 cannabis use disorder diagnosis and severity levels in adults with problematic substance use","volume":"155","author":"Fink","year":"2022","journal-title":"J Psychiatr Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/01419870.2018.1527937","article-title":"Racialization: A defense of the concept","volume":"42","author":"Hochman","year":"2019","journal-title":"Ethnic Racial Stud"},{"key":"B38","volume-title":"2015 NSDUH questionnaire redesign impact assessment, final report","year":""},{"key":"B39","unstructured":"2021 national survey on drug use and health: methodological summary and definitions"},{"key":"B40","unstructured":"2020 national survey on drug use and health: methodological summary and definitions"},{"key":"B41","volume-title":"2019 NSDUH MRB editing and imputation report","year":"2020"},{"key":"B42","unstructured":"FBI\n          \n          2025"},{"key":"B43","unstructured":"Treatment episode data set\u2014Admissions (TEDS-A) series"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2010.01100.x","article-title":"Comparing methods of racial and ethnic disparities measurement across different settings of mental health care","volume":"45","author":"L\u00ea Cook","year":"2010","journal-title":"Health Serv Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11414-018-9586-y","article-title":"Disparities in the treatment of substance use disorders: does where you live matter","volume":"45","author":"Acevedo","year":"2018","journal-title":"J Behav Health Serv Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2021.01409","article-title":"The problem of the color line: spatial access to hospital services for minoritized racial and ethnic groups","volume":"41","author":"Eberth","year":"2022","journal-title":"Health Affairs"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssmph.2018.04.003","article-title":"Beyond unequal access: Acculturation, race, and resistance to pharmaceuticalization in the United States","volume":"4","author":"Adams","year":"2018","journal-title":"SSM - Population Health"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.20240852","article-title":"Higher prevalence estimates of substance use disorders with DSM-5 versus DSM-IV criteria among U.S. Nonelderly adults with substance use: the role of DSM-IV diagnostic orphans","volume":"181","author":"Hasin","year":"2024","journal-title":"Am J Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.208957","article-title":"Screening, brief intervention, and referral to treatment (SBIRT) for cannabis: A scoping review","volume":"146","author":"Gette","year":"2023","journal-title":"J Subst Use Addict Treat"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1689719\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:28:53Z","timestamp":1762324133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2025.1689719\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":49,"alternative-id":["10.3389\/fpsyt.2025.1689719"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2025.1689719","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"article-number":"1689719"}}